Stempeutics Research Pvt Ltd: Clinical Trials

10 trials sponsored by Stempeutics Research Pvt Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 withdrawn. 8 Phase 2, 3 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 28Completed 6, Withdrawn 2
Phase 13Completed 2, Withdrawn 1
Phase 42Recruiting 2

Follow Stempeutics Research Pvt Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
Stempeucel® - Critical Limb Ischemia, Peripheral Arterial Disease
Phase 4RecruitingCell Biopeutics Resources Sdn Bhd102024-01-012025-09-09
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells - Critical Limb Ischemia, Buerger's Disease
Phase 4RecruitingCell Biopeutics Resources Sdn Bhd32024-01-012025-09-09
A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease
Stempeucel(R) - Critical Limb Ischemia Due to Buerger's Disease
Phase 2WithdrawnStempeutics Research Pvt Ltd2017-02-202017-04-07
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
Allogeneic Mesenchymal Stem Cells - Alcoholic Liver Cirrhosis
Phase 2CompletedStempeutics Research Pvt Ltd402012-06-012016-09-15
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
Allogeneic Mesenchymal Stem Cells - Critical Limb Ischemia, Buerger's Disease
Phase 2CompletedStempeutics Research Pvt Ltd902012-01-012016-09-13
Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke
Ex vivo cultured adult allogenic MSCs, Plasmalyte-A - Stroke
Phase 1 / Phase 2WithdrawnStempeutics Research Pvt Ltd2011-12-012016-05-12
Allogeneic Mesenchymal Stem Cells in Osteoarthritis
Ex- vivo cultured adult allogeneic MSCs, Plasmalyte-A - Osteoarthritis of Knee
Phase 2CompletedStempeutics Research Pvt Ltd602011-11-012016-05-12
Allogeneic Mesenchymal Stem Cells for Osteoarthritis
Ex- vivo cultured adult allogeneic MSCs, Plasmalyte-A - Osteoarthritis of Knee Joint
Phase 2CompletedStempeutics Research Pvt Ltd722011-09-012016-05-12
Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
Stem cell, Plasmalyte A - Myocardial Infarction
Phase 1 / Phase 2CompletedStempeutics Research Pvt Ltd202009-04-012013-03-05
Mesenchymal Stem Cells in Critical Limb Ischemia
mesenchymal stem cells, Plasmalyte A - Critical Limb Ischemia
Phase 1 / Phase 2CompletedStempeutics Research Pvt Ltd202009-04-012013-03-05

Conditions studied

Chronic Limb-Threatening Ischemia (4)  ·  Osteoarthritis (2)  ·  Thromboangiitis Obliterans (2)  ·  Fibrosis (1)  ·  Liver Cirrhosis, Alcoholic (1)  ·  Myocardial Infarction (1)  ·  Osteoarthritis, Knee (1)  ·  Peripheral Arterial Disease (1)  ·  Stroke (1)

Interventions

Plasmalyte A (5)

Countries

India (6)  ·  Malaysia (4)

Top investigators

Hanafiah Harunarashid, MS (2)  ·  Bhibas Dasgupta, MS (1)  ·  Dato' Dr. Ramli Baba, MS (1)  ·  Dr Abdul Syukur Abdullah, MD (1)  ·  Dr Alfred Augustine (1)  ·  Dr Anirban Chatterjee (1)  ·  Dr Anita Dhar (1)  ·  Dr Chuah Siew Kee, MD (1)  ·  Dr Dato K Chandran, MD (1)  ·  Dr Irene Looi, MD (1)  ·  Dr Murali Krishna (1)  ·  Dr Radhakrishnan R (1)  ·  Dr Rajiv Parakh (1)  ·  Dr Rajkumar M (1)  ·  Dr Sandeep Nijhwan Nijhwan, MD., DM (1)

Results publications

PMID 23758736, PMID 25484310, PMID 27993154